Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Atezolizumab in Combo w/ Gemcitabine & Cisplatin as First-Line Tx in Met Urothelial Cancer

Protocol: OSU-17141

Full Title

Atezolizumab in Combination with Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Multicenter Randomized Phase II Study of Two Alternative Dosing Schedules

Genitourinary Cancers Bladder Cancer